HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazunori Hamamura Selected Research

salubrinal

11/2021Suppression of alveolar bone resorption by salubrinal in a mouse model of periodontal disease.
10/2016Salubrinal improves mechanical properties of the femur in osteogenesis imperfecta mice.
4/2015Salubrinal acts as a Dusp2 inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritis.
6/2014Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediated downregulation of Rac1 signaling.
7/2013Effects of salubrinal on development of osteoclasts and osteoblasts from bone marrow-derived cells.
9/2012Salubrinal promotes healing of surgical wounds in rat femurs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazunori Hamamura Research Topics

Disease

15Neoplasms (Cancer)
01/2022 - 11/2006
15Melanoma (Melanoma, Malignant)
12/2021 - 08/2005
5Neoplasm Metastasis (Metastasis)
01/2017 - 10/2010
3Bone Resorption
11/2021 - 06/2014
3Lung Neoplasms (Lung Cancer)
08/2013 - 08/2005
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2012 - 08/2005
2Periodontitis
11/2021 - 11/2021
2Squamous Cell Carcinoma of Head and Neck
04/2021 - 08/2013
2Osteoporosis
05/2019 - 07/2013
2Virus Diseases (Viral Diseases)
01/2015 - 11/2013
2Osteosarcoma (Osteogenic Sarcoma)
12/2012 - 09/2012
1Periodontal Diseases (Periodontal Disease)
11/2021
1Osteogenesis Imperfecta (Lobstein Disease)
10/2016
1Chondrosarcoma
12/2015
1Metabolic Bone Diseases (Osteopenia)
10/2015
1Arthritis (Polyarthritis)
04/2015
1Inflammation (Inflammations)
04/2015
1Breast Neoplasms (Breast Cancer)
06/2014
1Triple Negative Breast Neoplasms
06/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2013
1Surgical Wound
09/2012
1Wounds and Injuries (Trauma)
09/2012
1Osteoarthritis
03/2009
1Joint Diseases (Joint Disease)
03/2009
1Hypoxia (Hypoxemia)
01/2008

Drug/Important Bio-Agent (IBA)

11GD3 ganglioside (GD(3))IBA
01/2018 - 08/2005
8GangliosidesIBA
12/2021 - 08/2005
6GlycolipidsIBA
01/2022 - 08/2008
6salubrinalIBA
11/2021 - 09/2012
6PaxillinIBA
08/2016 - 08/2005
5AntigensIBA
01/2022 - 08/2008
5IntegrinsIBA
12/2021 - 08/2005
3LipidsIBA
05/2019 - 04/2007
3Focal Adhesion Protein-Tyrosine KinasesIBA
08/2016 - 03/2008
3Tyrosine (L-Tyrosine)FDA Link
08/2008 - 11/2006
2CarbohydratesIBA
01/2022 - 08/2013
2EnzymesIBA
12/2021 - 05/2019
2Guanabenz (BR 750)FDA Link
11/2021 - 06/2014
2CytokinesIBA
11/2021 - 04/2015
2Epidermal Growth Factor (EGF)IBA
04/2021 - 06/2014
2Tumor Biomarkers (Tumor Markers)IBA
05/2019 - 08/2008
2GlycosphingolipidsIBA
05/2019 - 12/2012
2Messenger RNA (mRNA)IBA
01/2017 - 01/2008
2Small Interfering RNA (siRNA)IBA
08/2016 - 03/2008
2src-Family KinasesIBA
12/2015 - 05/2011
2Prokaryotic Initiation Factor-2IBA
01/2015 - 11/2013
2Syndecan-1 (Syndecan 1)IBA
08/2013 - 03/2012
2Tn antigenIBA
08/2013 - 03/2012
2Biological ProductsIBA
12/2012 - 10/2010
2Complementary DNA (cDNA)IBA
09/2012 - 09/2010
2p38 Mitogen-Activated Protein KinasesIBA
03/2009 - 01/2008
1Neoplasm Antigens (Tumor Antigens)IBA
01/2022
1GD2 gangliosideIBA
12/2021
1Tartrate-Resistant Acid PhosphataseIBA
11/2021
1Opioid Receptors (Opioid Receptor)IBA
05/2019
1Narcotic Antagonists (Opioid Antagonists)IBA
05/2019
1S100 Calcium-Binding Protein A4IBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1atelocollagenIBA
08/2016
1GTP Phosphohydrolases (GTPases)IBA
12/2015
1CollagenIBA
04/2015
1Progesterone Receptors (Progesterone Receptor)IBA
06/2014
1Estrogen ReceptorsIBA
06/2014
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2013
1A-Form DNA (A-DNA)IBA
08/2013
1Sialyl Lewis X AntigenIBA
08/2013
1Lewis Y antigenIBA
08/2013
1RANK LigandIBA
07/2013
1N-Acetylneuraminic Acid (Sialic Acid)IBA
12/2012
1Mechanistic Target of Rapamycin Complex 1IBA
07/2011
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2011
1CholesterolIBA
07/2011
1Proteins (Proteins, Gene)FDA Link
05/2011
1Bovine Serum AlbuminIBA
08/2008
1PhosphotyrosineIBA
03/2008
1ThapsigarginIBA
01/2008
1Phosphotransferases (Kinase)IBA
01/2008
1Caveolin 1IBA
04/2007
1Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA
11/2006
1Monoclonal AntibodiesIBA
08/2005
1AntibodiesIBA
08/2005

Therapy/Procedure

4Therapeutics
05/2019 - 11/2006
3Immunotherapy
01/2022 - 08/2008
1Transplantation
10/2015
1Molecular Targeted Therapy
09/2012
1Subcutaneous Injections
03/2012